Factors such as the growing incidence of
urolithiasis and technological advancements in lithotripsy devices are driving
the growth of this market.
The Lithotripsy
Devices Market is expected to reach USD 1.76 Billion by
2023 from USD 1.41 Billion in 2018, at a CAGR of 4.5%.
Download PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=29769904
By type, the lithotripsy devices market is
classified into extracorporeal shock wave lithotripsy devices and
intracorporeal lithotripsy devices. In 2017, the extracorporeal shock wave
lithotripsy devices segment accounted for the largest share of the market. ESWL
is the least invasive of all stone treatments and is considered the treatment
modality of choice for a majority of urinary stones.
On the basis of applications, the
lithotripsy devices market is categorized into kidney stones, ureteral stones,
pancreatic stones, and bile duct stones. In 2017, the kidney stones segment
accounted for the largest share of the market. The increasing incidence of
kidney stones and the recurrence of these stones over a period of time are the
key factors driving the growth of this segment.
On the basis of end user, the lithotripsy
devices market is categorized into hospitals, ambulatory surgical centers, and
other end users. In 2017, the hospitals segment accounted for the largest share
of the global lithotripsy devices market.
Based on region, the lithotripsy devices
market is segmented into North America, Europe, Asia, and the Rest of the World
(RoW). North America dominated the lithotripsy devices market in 2017.
Speak To Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=29769904
Some of the major players in the
lithotripsy devices market are Siemens AG (Germany), Boston Scientific (US),
Dornier MedTech (Germany), Olympus America (Japan), DirexGroup (Germany), and
Richard Wolf (Germany).
No comments:
Post a Comment